Skip to content

The role of dog-assisted therapy in rehabilitation, clinical recovery and improving quality of life

Dog-assisted rehabilitation: the role of animal-assisted therapy in clinical recovery and improving quality of life: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10208787
Enrollment
250
Registered
2022-03-15
Start date
2019-10-01
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of life of patients with neurological and musculoskeletal disorders Not Applicable

Interventions

Group dog therapy sessions are introduced once a week at South-Pest Central Hospital National Institute of Haematology and Infectology, Center for Rehabilitation, in Budapest, Hungary, with a trained

Sponsors

Semmelweis University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 18 years and over with neurological and musculoskeletal disorders (e.g. stroke, multiple sclerosis, arthrosis, amputation, bone fractures)

Exclusion criteria

Exclusion criteria: 1. Dog hair allergy 2. Immunosuppressed status 3. Early postoperative status 4. Age less than 18 years 4. Dementia 5. Refusal to participate in research 6. Decompensated physical and psychological status determined by the treating physician

Design outcomes

Primary

MeasureTime frame
1. Anxiety measured using the Spielberger State Anxiety Inventory (STAI) at baseline and after the last, third therapy session 2. Quality of life measured using the WHO Well-Being Index (WBI) at baseline and after the last, third therapy session 3. General condition and the impact of the therapy on different aspects of life measured using the Illness Intrusiveness Rating Scale (IIRS) at baseline and after the last, third therapy session

Secondary

MeasureTime frame
1. Depression measured using the Beck Depression Inventory (BDI-9) at baseline and after the last, third therapy session. 2. Pain measured using the Visual Analogue Scale (VAS) at baseline and after the last, third therapy session

Countries

Hungary

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026